StockData

Exousia Bio, Inc. (LMMY) stock

LMMYOTCServices-Educational ServicesFiscal year ends May 31
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026Score 4/30
$0.01−0.00 (-18.29%)

Close on Oct 19, 2026Market cap $175.47KP/E –Yield –

Exousia Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Exousia Bio's operating income for the twelve months ending Feb 29, 2024 was -$55.08K. For fiscal 2023 it was -$56.42K.

Annual operating income

PeriodPeriod endValueChange
FY2023May 31, 2023-$56.42K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Feb 28, 2026$0-100.0%
Q2 FY2026CQ4 2025Nov 30, 2025-$237.01K–
Q1 FY2026CQ3 2025Aug 31, 2025-$31.81K–
Q3 FY2025CQ1 2025Feb 28, 2025$0–
Q2 FY2025CQ4 2024Nov 30, 2024$6.98K–
Q1 FY2025CQ3 2024Aug 31, 2024-$4.34K–
Q3 FY2024CQ1 2024Feb 29, 2024-$8.70K–
Q2 FY2024CQ4 2023Nov 30, 2023-$7.45K–
Q1 FY2024CQ3 2023Aug 31, 2023-$12.16K–
Q4 FY2023CQ2 2023May 31, 2023-$26.78K–
Q3 FY2023CQ1 2023Feb 28, 2023-$8.27K–
Q2 FY2023CQ4 2022Nov 30, 2022-$8.41K–
Q1 FY2023CQ3 2022Aug 31, 2022-$12.97K–

More Exousia Bio figures

See a number that looks wrong?